Presentation By Windber Research Institute CSO Highlights Application Of InforSense Limited KDE To Translational Medicine
10/19/2005 5:10:23 PM
LONDON--(BUSINESS WIRE)--May 10, 2005--InforSense Ltd, the leader in integrative analytics platforms, invites life science researchers and media to attend a presentation entitled "Redefining Translational Medicine for Drug Discovery" at the Drug Discovery & Technology Leaders Summit to be held in Montreux, Switzerland. This presentation by Prof. Michael Liebman, Chief Scientific Officer of the Windber Research Institute (WRI), will describe the ground-breaking workflow-based informatics platform for translational medicine being developed in collaboration with InforSense at WRI.
Traditionally translational medicine has meant the translation of research at the bench to the bedside, i.e. into the clinic. In highlighting the Clinical Breast Care Project, jointly developed between WRI and its clinical collaborators, Prof. Liebman will demonstrate how their approach critically requires the need to also move from "bedside to bench". Enabling WRI's multi-disciplinary, clinical and molecular approach requires both an informatics infrastructure capable of integrating a wide variety of internal and external tools, algorithms, data types and data sources and also a rapid application development platform optimized for such a clinically driven 'top-down' approach for life science study. Both requirements will be met through the collaboration with InforSense and Prof. Liebman will describe the effort and the basis for this expanded view.
comments powered by